Track the Legend Biotech Corp stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €4.1bn. The latest transaction was filed on 18 August 2026 (Attribution). Among the most active insiders: Huang Ying. Every trade is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€75,025
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Legend Biotech Corp Buy (bullish), based on 15 analysts. Average price target: US$49.25.
30Σ signal
Buys n/a€75,025 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,991 of 29,062 companies
28.8
score / 100
Value
23
Quality
35
FCF yld-3.3%
Earn yld-7.7%
EV/EBITDA·
ROE-8.1%
Gross mgn60%
Net mgn-29%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.